Landos Biopharma, Inc. EPS - Earnings per Share 2021-2024 | LABP
Landos Biopharma, Inc. eps - earnings per share from 2021 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Landos Biopharma, Inc. Annual EPS |
| 2023 |
$-3.50 |
| 2022 |
$-9.76 |
| 2021 |
$-10.20 |
| 2020 |
$-24.70 |
| 2019 |
$-11.80 |
| Landos Biopharma, Inc. Quarterly EPS |
| 2024-03-31 |
$-1.43 |
| 2023-12-31 |
$-1.00 |
| 2023-09-30 |
$-0.94 |
| 2023-06-30 |
$-0.63 |
| 2023-03-31 |
$-0.93 |
| 2022-12-31 |
$-1.30 |
| 2022-09-30 |
$-1.96 |
| 2022-06-30 |
$-2.80 |
| 2022-03-31 |
$-3.70 |
| 2021-12-31 |
$-4.40 |
| 2021-09-30 |
$-3.20 |
| 2021-06-30 |
$1.20 |
| 2021-03-31 |
$-3.80 |
| 2020-12-31 |
$-5.80 |
| 2020-09-30 |
$-6.70 |
| 2020-06-30 |
$-7.30 |
| 2020-03-31 |
$-4.90 |
